Drug intelligence / Profile preview

recombinant human collagen hydrogel

Development stage
Unknown
Lead developer
Evonik
Modality
Hydrogel Systems → Drug Delivery Systems, Recombinant Proteins and Enzymes
Administration
Topical, Intramyocardial, Surgical Implant
01

Overview

Recombinant human collagen hydrogel is a biomaterial composed of laboratory-produced (recombinant) human collagen proteins formulated into a three-dimensional, water-rich gel. These hydrogels are engineered to mimic the natural extracellular matrix and provide structural support for tissue regeneration. They promote wound healing by stimulating cell proliferation, migration, angiogenesis (formation of new blood vessels), and enhanced deposition of native collagen[1][2][6]. Recombinant technology allows for high purity and batch-to-batch consistency compared to animal-derived collagens[4]. The hydrogels can be tailored with different types of recombinant human collagens (such as type I or III) and may be combined with other bioactive components or cells. Mechanistically, they act as scaffolds that facilitate tissue repair and can also serve as "sponges" to absorb toxic metabolites such as methylglyoxal after myocardial infarction[3]. Applications include chronic wound care (e.g., diabetic ulcers), skin injury repair, cardiac tissue regeneration post-myocardial infarction, and broader uses in regenerative medicine[1][3][5][6].

Brand names
VECOLLAN
Other names
recombinant human collagen hydrogelrhCol hydrogelrecombinant humanized collagen hydrogelrhCol III-CS hydrogel
02

Targets

Neuraminidase

Beyond the preview

Go deeper on recombinant human collagen hydrogel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant human collagen hydrogel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call